Effects of temperature on the experimental reliability of the isolated rat phrenic nerve/diaphragm preparation.

W. Colbert,B. Wilson,P. Williams

DOI: https://doi.org/10.1016/0160-5402(90)90049-Q

1990-08-01

Journal of Pharmacological Methods

Abstract:

What problem does this paper attempt to address?

Determinants of long‐term paramagnetic rim lesion evolution in people with multiple sclerosis

Jack A. Reeves,Alexander Bartnik,Maryam Mohebbi,Murali Ramanathan,Niels Bergsland,Dejan Jakimovski,Gregory E. Wilding,Fahad Salman,Ferdinand Schweser,Bianca Weinstock‐Guttman,David Hojnacki,Svetlana Eckert,Francesca Bagnato,Michael G. Dwyer,Robert Zivadinov

DOI: https://doi.org/10.1002/acn3.52253

IF: 5.43

2024-11-27

Annals of Clinical and Translational Neurology

Abstract:Objective Baseline paramagnetic rim lesion (PRL) load predicts disease progression in people with multiple sclerosis (pwMS). Understanding how PRLs relate to other known MS‐related factors, and the practical utility of PRLs in clinical trials, is crucial for informing clinical decision‐making and guiding development of novel disease‐modifying treatments (DMTs). Methods This study included 152 pwMS enrolled in a larger prospective, longitudinal cohort study who had 3T MRI scans and clinical assessments at baseline and 5‐ or 10‐year follow‐ups. PRLs were identified on baseline 3T quantitative susceptibility maps and classified as persisting, disappearing, or newly appearing at follow‐up. The relationships between PRL evolution and clinical, radiological, environmental, and genetic characteristics were assessed, and clinical trial sample sizes were estimated using PRL appearance or disappearance as outcome measures. Results DMT use was associated with lower odds of new PRL appearance (for high‐efficacy DMTs: odds ratio = 0.088, p = 0.024), but not disappearance. Current smoking status was associated with greater baseline PRL number (B = 0.527 additional PRLs, p = 0.013). A 24‐month clinical trial in people with progressive MS for a DMT that doubles the rate of PRL rim disappearance would require an estimated 118 people with progressive MS per group at 80% statistical power. Interpretation Early MS diagnosis and subsequent DMT initiation may reduce new chronic active inflammation. However, the utility of PRL disappearance or new PRL appearance as outcome measures in clinical trials is limited by potentially large sample sizes that are needed for moderate efficacy drugs.

neurosciences,clinical neurology
Paramagnetic rim lesions are associated with inner retinal layer thinning and progression independent of relapse activity in multiple sclerosis

Nik Krajnc,Leo Hofer,Fabian Föttinger,Assunta Dal‐Bianco,Fritz Leutmezer,Barbara Kornek,Paulus Rommer,Gregor Kasprian,Thomas Berger,Berthold Pemp,Lukas Haider,Gabriel Bsteh

DOI: https://doi.org/10.1111/ene.16529

2024-11-16

European Journal of Neurology

Abstract:Background and purpose Paramagnetic rim lesions (PRLs) are chronic active lesions associated with a severe disease course in multiple sclerosis (MS). This study was undertaken to investigate an association between retinal layer thinning (annualized loss of peripapillary retinal nerve fiber layer [aLpRNFL] and ganglion cell–inner plexiform layer [aLGCIPL]) and PRLs in patients with MS (pwMS). Methods In this study, pwMS with brain magnetic resonance imaging and ≥2 optical coherence tomography scans were included. Cox proportional hazard regression models were performed using progression independent of relapse activity (PIRA) as the dependent variable, and aLpRNFL, aLGCIPL, or the number of PRLs as independent variables, adjusted for covariates. Results We analyzed data from 97 pwMS (mean age = 35.2 years [SD = 9.9], 71.1% female, median disease duration = 2.3 years [interquartile range = 0.9–9.0]). The number of PRLs was associated with aLpRNFL and aLGCIPL. PIRA was observed in 18 (18.6%) pwMS, with aLpRNFL (hazard ratio [HR] = 1.44 per %/year), aLGCIPL (HR = 1.61 per %/year), and the number of PRLs (HR = 1.24 per PRL) being associated with increased risk of PIRA. Conclusions The number of PRLs is associated with inner retinal layer thinning and increased risk of PIRA. A combination of PRLs and retinal layer thinning could serve as a surrogate for pwMS at highest risk of disability progression.

neurosciences,clinical neurology
Longitudinal Multiparametric Quantitative MRI Evaluation of Acute and Chronic Multiple Sclerosis Paramagnetic Rim Lesions

Ahmed M Elkady,Colm Elliott,Dumitru Fetco,David Araujo,Zahra Karimaghaloo,Marco Ganzetti,David Clayton,Licinio Craveiro,Agne Kazlauskaite,Sridar Narayanan,Douglas L Arnold,David A Rudko

DOI: https://doi.org/10.1002/jmri.29583

2024-09-06

Abstract:Background: Multiple sclerosis (MS) paramagnetic rim lesions (PRLs) are markers of chronic active biology and exhibit complex iron and myelin changes that may complicate quantification when using conventional MRI approaches. Purpose: To conduct a multiparametric MRI analysis of PRLs. Study type: Retrospective/longitudinal. Subjects: Ninety-five progressive MS subjects with at least one persistent PRL who were enrolled in the CONSONANCE trial. Field strength/sequence: 3-T/Susceptibility-weighted, T1-weighted, T2-weighted, and fluid-attenuated inversion recovery. Assessment: Acute/chronic PRLs and non-PRLs were measured at screening, 24, 48, and 96 weeks using quantitative magnetic susceptibility (QS), R2*, and standardized T1w/T2w ratio (sT1w/T2w). PRL analyses were performed for whole lesion, core, and rim. The correlations between PRL core and rim sT1w/T2w, QS, and R2* were assessed. Statistical tests: Linear mixed models. A P-value <0.05 was considered significant. Results: There was a significant decrease in sT1w/T2w (-0.24 ± -5.3 × 10-3) and R2* (-3.6 ± 2.2 Hz) but a significant increase in QS (+21 ± 1.3 ppb) using whole-lesion analysis of chronic PRLs compared to non-PRLs at screening. Tissue damage accumulated at the 96-week time point was more evident in acute/chronic PRLs compared to acute/chronic non-PRLs (ΔsT1w/T2w = -0.21/-0.24 ± 0.033/0.0053; ΔR2* = -4.4/-3.6 ± 1.4/2.2 Hz). New, acute PRL sT1w/T2w significantly increased in lesion core (+4.3 × 10-3 ± 1.2 × 10-4) and rim (+5.6 × 10-3 ± 1.2 × 10-4) 24 weeks post lesion inception, suggestive of partial recovery. Chronic PRLs, contrastingly, showed significant decreases in sT1w/T2w over the initial 24 weeks for both core (-2.1 × 10-4 ± 2.0 × 10-5) and rim (-2.4 × 10-4 ± 2.0 × 10-5), indicative of irreversible tissue damage. Significant positive correlations between PRL core and rim sT1w/T2w (R2 = 0.53), R2* (R2 = 0.69) and QS (R2 = 0.52) were observed. Data conclusion: Multiparametric assessment of PRLs has the potential to be a valuable tool for assessing complex iron and myelin changes in chronic active PRLs of progressive MS patients. Level of evidence: 2 TECHNICAL EFFICACY: Stage 3.
Prognostic significance of paramagnetic rim lesions in multiple sclerosis: A systematic review

Adon Toru Asahina,Joe Lu,Pooja Chugh,Srishti Sharma,Prakriti Sharma,Sheryn Tan,Joshua Kovoor,Brandon Stretton,Aashray Gupta,Annabel Sorby-Adams,Rudy Goh,Adil Harroud,Margareta A Clarke,Nikos Evangelou,Sandy Patel,Andrew Dwyer,Marc Agzarian,Stephen Bacchi,Mark Slee

DOI: https://doi.org/10.1016/j.jocn.2024.110810

2024-09-03

Abstract:The diagnostic potential of paramagnetic rim lesions (PRLs) has been previously established; however, the prognostic significance of these lesions has not previously been consistently described. This study aimed to establish the prognostic role of PRLs in MS with respect to the Expanded Disability Status Scale (EDSS) and rates of disability progression. Databases of PubMed, EMBASE, Scopus and reference lists of selected articles were searched up to 29/04/2023. The review was conducted in accordance with PRISMA guidelines and was registered prospectively on PROSPERO (CRD42023422052). 7 studies were included in the final review. All of the eligible studies found that patients with PRLs tend to have higher baseline EDSS scores. Longitudinal assessments revealed greater EDSS progression in patients with PRLs over time in most studies. However, the effect of location of PRLs within the central nervous system were not assessed across the studies. Only one study investigated progression independent of relapse activity (PIRA) and showed that this clinical entity occurred in a greater proportion in patients with PRLs. This review supports PRLs as a predictor of EDSS progression. This measure has widespread applicability, however further multicentre studies are needed. Future research should explore the impact of PRLs on silent disability, PIRA, take into account different MS phenotypes and the topography of PRLs in prognosis.
Evaluation of the Blood‐Brain Barrier, Demyelination, and Neurodegeneration in Paramagnetic Rim Lesions in Multiple Sclerosis on 7 Tesla MRI

Seongjin Choi,Sarah Lake,Daniel M. Harrison

DOI: https://doi.org/10.1002/jmri.28847

IF: 4.4

2023-06-06

Journal of Magnetic Resonance Imaging

Abstract:Background Paramagnetic rim lesions (PRLs) are associated with chronic inflammation in multiple sclerosis (MS). 7‐Tesla (7T) magnetic resonance imaging (MRI) can evaluate the integrity of the blood‐brain barrier (BBB) in addition to the tissue myelination status and cell loss. Purpose To use MRI metrics to investigate underlying physiology and clinical importance of PRLs. Study Type Prospective. Subjects Thirty‐six participants (mean‐age 47, 23 females, 13 males) of mixed MS subtypes. Field Strength/Sequence 7T, MP2RAGE, MULTI‐ECHO 3D‐GRE, FLAIR. Assessment Lesion heterogeneity; longitudinal changes in lesion counts; comparison of T1, R2*, and χ; association between baseline lesion types and disease progression (2–3 annual MRI visits with additional years of annual clinical follow‐up). Statistical Tests Two‐sample t‐test, Wilcoxon Rank‐Sum test, Pearson's chi‐square test, two‐group comparison with linear‐mixed‐effect model, mixed‐effect ANOVA, logistic regression. P‐values <0.05 were considered significant. Results A total of 58.3% of participants had at least one PRL at baseline. Higher male proportion in PRL+ group was found. Average change in PRL count was 0.20 (SD = 2.82) for PRLs and 0.00 (SD = 0.82) for mottled lesions. Mean and median pre‐/post‐contrast T1 were longer in PRL+ than in PRL−. No differences in mean χ were seen for lesions grouped by PRL (P = 0.310, pre‐contrast; 0.086, post‐contrast) or PRL/M presence (P = 0.234, pre‐contrast; 0.163, post‐contrast). Median χ were less negative in PRL+ and PRL/M+ than in PRL− and PRL/M−. Mean and median pre−/post‐contrast R2* were slower in PRL+ compared to PRL−. Mean and median pre−/post‐contrast R2* were slower in PRL/M+ than in PRL/M−. PRL presence at baseline was associated with confirmed EDSS Plus progression (OR 3.75 [1.22–7.59]) and PRL/M+ at baseline with confirmed EDSS Plus progression (OR 3.63 [1.14–7.43]). Data Conclusion Evidence of BBB breakdown in PRLs was not seen. Quantitative metrics confirmed prior results suggesting greater demyelination, cell loss, and possibly disruption of tissue anisotropy in PRLs. Evidence Level 2 Technical Efficacy Stage 2

radiology, nuclear medicine & medical imaging
Paramagnetic Rim Lesions are Highly Specific for Multiple Sclerosis in Real-World Data

Christopher C Hemond,Sathish Dundamadappa,Mugdha Deshpande,Jonggyu Baek,Robert H. Brown,Carolina Ionete,Daniel S Reich

DOI: https://doi.org/10.1101/2024.08.14.24312000

2024-08-20

Abstract:Introduction: Paramagnetic rim lesions (PRL) are an emerging biomarker for multiple sclerosis (MS). In addition to associating with greater disease severity, PRL may be diagnostically supportive. Objective: Our aim was to determine PRL specificity and sensitivity for discriminating MS from its diagnostic mimics using real-world clinical diagnostic and imaging data. Methods: This is a retrospective, cross-sectional analysis of a longitudinal cohort of patients with prospectively collected observational data. Patients were included if they underwent neuroimmunological evaluation in our academic MS center, and had an available MRI scan from the same clinical 3T magnet that included a T2*-weighted sequence with susceptibility postprocessing (SWAN protocol, GE). SWAN-derived filtered phase maps and corresponding T2-FLAIR images were manually reviewed to determine PRL. PRL were categorized as "definite," "probable," or "possible" based on modified, recent consensus criteria. We hypothesized that PRL would convey a high specificity to discriminate MS from its MRI mimics. Results: 580 patients were evaluated in total: 473 with MS, 57 with non-inflammatory neurological disease (NIND), and 50 with other inflammatory neurological disease (OIND). Identification of "definite" or "probable" PRL provided a specificity of 98% to discriminate MS from NIND and OIND; sensitivity was 36%. Interrater agreement was almost perfect for definite/probable identification at a subject level. Interpretation: PRL convey high specificity for MS and can aid in the diagnostic evaluation. Modest sensitivity limits their use as single diagnostic indicators. Including lesions with lower confidence ("possible" PRL) rapidly erodes specificity and should be interpreted with caution given the potential harms associated with misdiagnosis.
The effect of a single dose of cyclophosphamide on the kinetics of antibody production in the guinea pig.

K. Drössler,D. Parker,J. Turk

DOI: https://doi.org/10.1016/0192-0561(83)90035-8

International Journal of Immunopharmacology

Abstract:
Chronic active lesions preferentially localize in watershed territories in multiple sclerosis

Ahmad A. Toubasi,Jarrod J. Eisma,Jiacheng Wang,Habeeb F. Kazimuddin,Bryan Hernandez,Taegan Vinarsky,Caroline Gheen,Zachary Rohm,Carynn Koch,Margareta A. Clarke,Rachael Cheek,John Kramer,James Eaton,Manus J. Donahue,Francesca Bagnato

DOI: https://doi.org/10.1002/acn3.52202

IF: 5.43

2024-10-26

Annals of Clinical and Translational Neurology

Abstract:Objective Paramagnetic rim lesions (PRLs) are a biomarker of chronic active lesions (CALs), and an important driver of neurological disability in multiple sclerosis (MS). The reason subtending some acute lesions evolvement into CALs is not known. Here we ask whether a relatively lower oxygen content is linked to CALs. Methods In this prospective cross‐sectional study, 64 people with multiple sclerosis (PwMS), clinically isolated syndrome and radiologically isolated syndrome underwent a 7.0 Tesla (7 T) brain magnetic resonance imaging (MRI). The scanning protocol included a T2‐w fluid‐attenuated inversion recovery (FLAIR), and a single echo gradient echo from which susceptibility‐weighted imaging (SWI) was derived. WM lesions were identified on the T2‐w‐FLAIR whilst PRLs were identified on the SWI sequence. T2‐lesions were classified as PRLs and rimless lesions (PRLs‐). We registered a universal vascular atlas to each subject's T2‐w‐FLAIR and classified each T2‐lesions according to its location into watershed‐ (ws), non‐watershed‐ (nws), and mixed‐lesion (m). Ws‐lesions were defined as lesions that were fully located in a region between the territories of two major arteries. Results Out of 1,975 T2‐lesions, 88 (4.5%) were PRLs. Ws‐regions had a higher number (p = 0.005) and proportion (p

neurosciences,clinical neurology
Multicenter validation of automated detection of paramagnetic rim lesions on brain MRI in multiple sclerosis

Luyun Chen,Zheng Ren,Kelly A. Clark,Carolyn Lou,Fang Liu,Quy Cao,Abigail R. Manning,Melissa L. Martin,Elaina Luskin,Carly M. O'Donnell,Christina J. Azevedo,Peter A. Calabresi,Leorah Freeman,Roland G. Henry,Erin E. Longbrake,Jiwon Oh,Nico Papinutto,Michel Bilello,Jae W. Song,Marwa Kaisey,Nancy L. Sicotte,Daniel S. Reich,Andrew J. Solomon,Daniel Ontaneda,Pascal Sati,Martina Absinta,Matthew K. Schindler,Russell T. Shinohara,the NAIMS Cooperative

DOI: https://doi.org/10.1111/jon.13242

2024-10-17

Journal of Neuroimaging

Abstract:Background and Purpose Paramagnetic rim lesions (PRLs) are an MRI biomarker of chronic inflammation in people with multiple sclerosis (MS). PRLs may aid in the diagnosis and prognosis of MS. However, manual identification of PRLs is time‐consuming and prone to poor interrater reliability. To address these challenges, the Automated Paramagnetic Rim Lesion (APRL) algorithm was developed to automate PRL detection. The primary objective of this study is to evaluate the accuracy of APRL for detecting PRLs in a multicenter setting. Methods We applied APRL to a multicenter dataset, which included 3‐Tesla MRI acquired in 92 participants (43 with MS, 14 with clinically isolated syndrome [CIS]/radiologically isolated syndrome [RIS], 35 without RIS/CIS/MS). Subsequently, we assessed APRL's performance by comparing its results with manual PRL assessments carried out by a team of trained raters. Results Among the 92 participants, expert raters identified 5637 white matter lesions and 148 PRLs. The automated segmentation method successfully captured 115 (78%) of the manually identified PRLs. Within these 115 identified lesions, APRL differentiated between manually identified PRLs and non‐PRLs with an area under the curve (AUC) of .73 (95% confidence interval [CI]: [.68, .78]). At the subject level, the count of APRL‐identified PRLs predicted MS diagnosis with an AUC of .69 (95% CI: [.57, .81]). Conclusion Our study demonstrated APRL's capability to differentiate between PRLs and lesions without paramagnetic rims in a multicenter study. Automated identification of PRLs offers greater efficiency over manual identification and could facilitate large‐scale assessments of PRLs in clinical trials.

radiology, nuclear medicine & medical imaging,clinical neurology,neuroimaging
Paramagnetic rim lesions as a biomarker to discriminate between multiple sclerosis and cerebral small vessel disease

Zhibao Zhu,Yuanyuan Zhang,Chun Li,Wenliang Guo,Zhili Chen,Wei Chen,Shaowu Li,Ning Wang,Xiaochun Chen,Ying Fu

DOI: https://doi.org/10.3389/fneur.2024.1429698

2024-07-16

Abstract:Background: Multiple sclerosis (MS) and Cerebral Small Vessel Disease (CSVD) exhibit some similarities in Magnetic resonance imaging (MRI), potentially leading to misdiagnosis and delaying effective treatment windows. It is unclear whether CSVD can be detected with Paramagnetic Rim Lesions (PRL), which is special in MS. Objective: We aimed to investigate whether PRL can serve as a neuroimaging marker for discriminating between MS and CSVD. Methods: In this retrospective study, 49 MS and 104 CSVD patients underwent 3.0 T Magnetic resonance imaging (MRI). Visual assessment of 37 MS patients and 89 CSVD patients with or without lacunes, cerebral microbleeds (CMBs), enlarged perivascular spaces (EPVS), white matter hyperintensity (WMH), central vein sign (CVS), and PRL. The distribution and number of PRL were then counted. Results: Our study found that PRL was detected in over half of the MS patients but was entirely absent in CSVD patients (78.38 vs. 0%, p < 0.0001), and PRL showed high specificity with good sensitivity in discriminating between MS and CSVD (sensitivity: 78.38%, specificity: 100%, AUC: 0.96). Conclusion: Paramagnetic Rim Lesions is a special imaging feature in MS, absent in CSVD. Detection of PRL can be very helpful in the clinical management of MS and CSVD.
Clinical relevance of paramagnetic rim lesion heterogeneity in multiple sclerosis

Anna Stölting,Colin Vanden Bulcke,Serena Borrelli,Céline Bugli,Renaud Du Pasquier,Vincent van Pesch,Pietro Maggi

DOI: https://doi.org/10.1002/acn3.52220

IF: 5.43

2024-10-11

Annals of Clinical and Translational Neurology

Abstract:Objective Previous studies reveal heterogeneity in terms of paramagnetic rim lesions (PRL) associated tissue damage. We investigated the physiopathology and clinical implications of this heterogeneity. Methods In 103 MS patients (72 relapsing and 31 progressive), brain lesions were manually segmented on 3T 3D‐FLAIR and rim visibility was assessed with a visual confidence level score (VCLS) on 3D‐EPI phase. Using T1 relaxation time maps, lesions were categorized in long‐T1 and short‐T1. Lesion age was calculated from time of first gadolinium enhancement (N = 84 lesions). Results on clinical scores were validated in an extended cohort of 167 patients using normalized T1w‐MPRAGE lesion values. Results Rim visibility (VCLS analysis) was associated with increasing lesional T1 (P/PFDR

neurosciences,clinical neurology
The contribution of paramagnetic rim and cortical lesions to physical and cognitive disability at multiple sclerosis clinical onset: evaluating the power of MRI and OCT biomarkers

Alessandro Miscioscia,Caterina Mainero,Constantina A Treaba,Erica Silvestri,Graziana Scialpi,Angela Berardi,Francesco Causin,Maria Giulia Anglani,Francesca Rinaldi,Paola Perini,Marco Puthenparampil,Alessandra Bertoldo,Paolo Gallo

DOI: https://doi.org/10.1007/s00415-024-12622-8

2024-08-19

Abstract:Background: In multiple sclerosis (MS), imaging biomarkers play a crucial role in characterizing the disease at the time of diagnosis. MRI and optical coherence tomography (OCT) provide readily available biomarkers that may help to define the patient's clinical profile. However, the evaluation of cortical and paramagnetic rim lesions (CL, PRL), as well as retinal atrophy, is not routinely performed in clinic. Objective: To identify the most significant MRI and OCT biomarkers associated with early clinical disability in MS. Methods: Brain, spinal cord (SC) MRI, and OCT scans were acquired from 45 patients at MS diagnosis to obtain: brain PRL and non-PRL, CL, SC lesion volumes and counts, brain volumetric metrics, SC C2-C3 cross-sectional area, and retinal layer thickness. Regression models assessed relationships with physical disability (Expanded Disability Status Scale [EDSS]) and cognitive performance (Brief International Cognitive Assessment for Multiple Sclerosis [BICAMS]). Results: In a stepwise regression (R2 = 0.526), PRL (β = 0.001, p = 0.023) and SC lesion volumes (β = 0.001, p = 0.017) were the most significant predictors of EDSS, while CL volume and age were strongly associated with BICAMS scores. Moreover, in a model where PRL and non-PRL were pooled, only the contribution of SC lesion volume was retained in EDSS prediction. OCT measures did not show associations with disability at the onset. Conclusion: At MS onset, PRL and SC lesions exhibit the strongest association with physical disability, while CL strongly contribute to cognitive performance. Incorporating the evaluation of PRL and CL into the initial MS patient assessment could help define their clinical profile, thus supporting the treatment choice.
Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosis

Annika Hofmann,Nik Krajnc,Assunta Dal-Bianco,Christian J. Riedl,Tobias Zrzavy,Celia Lerma-Martin,Gregor Kasprian,Claudia E. Weber,Francesco Pezzini,Fritz Leutmezer,Paulus Rommer,Gabriel Bsteh,Michael Platten,Achim Gass,Thomas Berger,Philipp Eisele,Roberta Magliozzi,Lucas Schirmer,Simon Hametner

DOI: https://doi.org/10.1007/s00401-023-02627-4

IF: 15.887

2023-09-17

Acta Neuropathologica

Abstract:In multiple sclerosis (MS), sustained inflammatory activity can be visualized by iron-sensitive magnetic resonance imaging (MRI) at the edges of chronic lesions. These paramagnetic rim lesions (PRLs) are associated with clinical worsening, although the cell type-specific and molecular pathways of iron uptake and metabolism are not well known. We studied two postmortem cohorts: an exploratory formalin-fixed paraffin-embedded (FFPE) tissue cohort of 18 controls and 24 MS cases and a confirmatory snap-frozen cohort of 6 controls and 14 MS cases. Besides myelin and non-heme iron imaging, the haptoglobin-hemoglobin scavenger receptor CD163, the iron-metabolizing markers HMOX1 and HAMP as well as immune-related markers P2RY12, CD68, C1QA and IL10 were visualized in myeloid cell (MC) subtypes at RNA and protein levels across different MS lesion areas. In addition, we studied PRLs in vivo in a cohort of 98 people with MS (pwMS) via iron-sensitive 3 T MRI and haptoglobin genotyping by PCR. CSF samples were available from 38 pwMS for soluble CD163 (sCD163) protein level measurements by ELISA. In postmortem tissues, we observed that iron uptake was linked to rim-associated C1QA -expressing MC subtypes, characterized by upregulation of CD163 , HMOX1 , HAMP and, conversely, downregulation of P2RY12 . We found that pwMS with 4 PRLs had higher sCD163 levels in the CSF than pwMS with 3 PRLs with sCD163 correlating with the number of PRLs. The number of PRLs was associated with clinical worsening but not with age, sex or haptoglobin genotype of pwMS. However, pwMS with Hp2-1/Hp2-2 haplotypes had higher clinical disability scores than pwMS with Hp1-1 . In summary, we observed upregulation of the CD163-HMOX1-HAMP axis in MC subtypes at chronic active lesion rims, suggesting haptoglobin-bound hemoglobin but not transferrin-bound iron as a critical source for MC-associated iron uptake in MS. The correlation of CSF-associated sCD163 with PRL counts in MS highlights the relevance of CD163-mediated iron uptake via haptoglobin-bound hemoglobin. Also, while Hp haplotypes had no noticeable influence on PRL counts, pwMS carriers of a Hp2 allele might have a higher risk to experience clinical worsening.

pathology,neurosciences,clinical neurology
History of diagnostic enzymology: a review of significant investigations.

P. Wolf

DOI: https://doi.org/10.1016/J.CCA.2006.02.043

2006-07-31

Abstract:
Impact of paramagnetic rim lesions on disability and race in multiple sclerosis: mediation analysis

Nara M. Michaelson,Sandra H. Rúa,Ulrike W. Kaunzner,Melanie Marcille,Iliana Pliska‐Bloch,Kimberly Markowitz,Thanh D. Nguyen,Susan A. Gauthier

DOI: https://doi.org/10.1002/acn3.52203

IF: 5.43

2024-09-19

Annals of Clinical and Translational Neurology

Abstract:Objective Black American (BA) multiple sclerosis (MS) patients experience greater disability compared to White American (WA) patients. Here, we investigated the role of paramagnetic rim lesions (PRLs), a subset of chronic active lesions, on race‐related disability in MS. Methods We conducted a retrospective observational study comparing BA and WA MS patients. PRLs were identified through Quantitative Susceptibility Mapping (QSM) MRI. A causal mediation analysis explored the impact of PRLs on the relationship between race and disability, as measured by the Expanded Disability Status Scale (EDSS). Results The prevalence of PRLs in BA patients with MS was higher at 55% compared to WA patients at 39% (p = 0.022). A higher percentage of PRLs among all white matter lesions was observed with BA (8.01%) patients compared to WA (3.4%) patients (p = 0.003). In a regression analysis, controlling for significant patient‐level covariates and income‐level demographics, the percentage of PRLs was, on average, 4.61 points higher for BA patients than for WA patients (p = 0.003). In a separate regression analysis, accounting for covariates, BA patients exhibited significantly higher EDSS scores (p

neurosciences,clinical neurology
Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis

Christian Barro,Brian C. Healy,Yanqing Liu,Shrishti Saxena,Anu Paul,Mariann Polgar-Turcsanyi,Charles R.G. Guttmann,Rohit Bakshi,Harald Kropshofer,Howard L. Weiner,Tanuja Chitnis

DOI: https://doi.org/10.1212/NXI.0000000000200052

2022-11-16

Neurology: Neuroimmunology and NeuroInflammation

Abstract:Background and Objectives Neurodegeneration and astrocytic activation are pathologic hallmarks of progressive multiple sclerosis (MS) and can be quantified by serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP). We investigated sNfL and sGFAP as tools for stratifying patients with progressive MS based on progression and disease activity status. Methods We leveraged our Comprehensive Longitudinal Investigation of MS at the Brigham and Women9s Hospital (CLIMB) natural history study, which includes clinical, MRI data and serum samples collected over more than 20 years. We included patients with MS with a confirmed Expanded Disability Status Scale (EDSS) score ≥3 that corresponds with our classifier for patients at high risk of underlying progressive pathology. We analyzed sNfL and sGFAP within 6 months from the confirmed EDSS score ≥3 corresponding with our baseline visit. Patients who further developed 6-month confirmed disability progression (6mCDP) were classified as progressors. We further stratified our patients into active/nonactive based on new brain/spinal cord lesions or relapses in the 2 years before baseline or during follow-up. Statistical analysis on log-transformed sGFAP/sNfL assessed the baseline association with demographic, clinical, and MRI features and associations with future disability. Results We included 257 patients with MS who had an average EDSS score of 4.0 and a median follow-up after baseline of 7.6 years. sNfL was higher in patients with disease activity in the 2 years before baseline (adjusted β = 1.21; 95% CI 1.04–1.42; p = 0.016), during the first 2 years of follow-up (adjusted β = 1.17; 95% CI = 1.01–1.36; p = 0.042). sGFAP was not increased in the presence of disease activity. Higher sGFAP levels, but not sNfL levels, were associated with higher risk of 6mCDP (adjusted hazard ratio [HR] = 1.71; 95% CI = 1.19–2.45; p = 0.004). The association was stronger in patients with low sNfL (adjusted HR = 2.44; 95% CI 1.32–4.52; p = 0.005) and patients who were nonactive in the 2 years prior or after the sample. Discussion Higher levels of sGFAP correlated with subsequent progression, particularly in nonactive patients, whereas sNfL reflected acute disease activity in patients with MS at high risk of underlying progressive pathology. Thus, sGFAP and sNfL levels may be used to stratify patients with progressive MS for clinical research studies and clinical trials and may inform clinical care.
Using the Progression Independent of Relapse Activity Framework to Unveil the Pathobiological Foundations of Multiple Sclerosis

Olga Ciccarelli,Frederik Barkhof,Massimiliano Calabrese,Nicola De Stefano,Arman Eshaghi,Massimo Filippi,Claudio Gasperini,Cristina Granziera,Ludwig Kappos,Maria A Rocca,Àlex Rovira,Jaume Sastre-Garriga,Maria Pia Sormani,Carmen Tur,Ahmed T Toosy,as the MAGNIMS Study Group

DOI: https://doi.org/10.1212/WNL.0000000000209444

IF: 9.9

2024-07-09

Neurology

Abstract:Progression independent of relapse activity (PIRA), a recent concept to formalize disability accrual in multiple sclerosis (MS) independent of relapses, has gained popularity as a potential clinical trial outcome. We discuss its shortcomings and appraise the challenges of implementing it in clinical settings, experimental trials, and research. The current definition of PIRA assumes that acute inflammation, which can manifest as a relapse, and neurodegeneration, manifesting as progressive disability accrual, can be disentangled by introducing specific time windows between the onset of relapses and the observed increase in disability. The term PIRMA (progression independent of relapse and MRI activity) was recently introduced to indicate disability accrual in the absence of both clinical relapses and new brain and spinal cord MRI lesions. Assessing PIRMA in clinical practice is highly challenging because it necessitates frequent clinical assessments and brain and spinal cord MRI scans. PIRA is commonly assessed using Expanded Disability Status Scale, a scale heavily weighted toward motor disability, whereas a more granular assessment of disability deterioration, including cognitive decline, using composite measures or other tools, such as digital tools, would possess greater utility. Similarly, using PIRA as an outcome measure in randomized clinical trials is also challenging and requires methodological considerations. The underpinning pathobiology of disability accumulation, that is not associated with relapses, may encompass chronic active lesions (slowly expanding lesions and paramagnetic rim lesions), cortical lesions, brain and spinal cord atrophy, particularly in the gray matter, diffuse and focal microglial activation, persistent leptomeningeal enhancement, and white matter tract damage. We propose to use PIRA to understand the main determinant of disability accrual in observational, cohort studies, where regular MRI scans are not included, and introduce the term of "advanced-PIRMA" to investigate the contributions to disability accrual of the abovementioned processes, using conventional and advanced imaging. This is supported by the knowledge that MRI reflects the MS pathogenic mechanisms better than purely clinical descriptors. Any residual disability accrual, which remains unexplained after considering all these mechanisms with imaging, will highlight future research priorities to help complete our understanding of MS pathogenesis.
Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life setting

Johanna von Gumberz,Mina Mahmoudi,Kim Young,Sven Schippling,Roland Martin,Christoph Heesen,Susanne Siemonsen,Jan-Patrick Stellmann

DOI: https://doi.org/10.7717/peerj.2442

IF: 3.061

2016-09-20

PeerJ

Abstract:Background Magnetic resonance imaging (MRI) is the best biomarker of inflammatory disease activity in relapsing remitting Multiple Sclerosis (RRMS) so far but the association with disability is weak. Appearance of new MRI-lesions is used to evaluate response to immunotherapies in individual patients as well as being the most common primary outcome in phase-2 trials. Measurements of brain atrophy show promising outcomes in natural cohort studies and some phase-2 trials. From a theoretical perspective they might represent irreversible neurodegeneration and be more closely associated with disability. However, these atrophy measurements are not yet established as prognostic factors in real-life clinical routine. High field MRI has improved image quality and resolution and new methods to measure atrophy dynamics have become available. Objective To investigate the predictive value of MRI classification criteria in to high/low atrophy and inflammation groups, and to explore predictive capacity of two consecutive routine MRI scans for disability progression in RRMS in a real-life prospective cohort. Methods 82 RRMS-patients (40 untreated, 42 treated with immunotherapies, mean age 40 years, median Expanded Disability Status Scale (EDSS) of 2, underwent two clinically indicated MRI scans (3 Tesla) within 5–14 months, and EDSS assessment after a mean of 3.0 (1.5–4.2) years. We investigated the predictive value of predefined classifications in low/high inflammatory and atrophy groups for EDSS progression (≥1.5 if baseline EDSS = 0, ≥1.0 if baseline EDSS <5, ≥0.5 for other) by chi-square tests and by analysis of variance (ANOVA). The classifications were based on current scientific or clinical recommendation (e.g., treatment response criteria). Brain atrophy was assessed with three different methods (SIENA, SIENAX, and FreeSurfer). Post-hoc analyses aimed to explore clinical data and dynamics of MRI outcomes as predictors in multivariate linear and logit models. Results Progression was observed in 24% of patients and was independent from treatment status. None of the predefined classifications were predictive for progression. Explorative post-hoc analyses found lower baseline EDSS and higher grey matter atrophy (FreeSurfer) as best predictors ( R 2 = 0.29) for EDSS progression and the accuracy was overall good (Area under the curve = 0.81). Conclusion Beside EDSS at baseline, short-term grey matter atrophy is predictive for EDSS progression in treated and untreated RRMS. The development of atrophy measurements for individual risk counselling and evaluation of treatment response seems possible, but needs further validation in larger cohorts. MRI-atrophy estimates from the FreeSurfer toolbox seem to be more reliable than older methods.

multidisciplinary sciences
Chronic Active Lesions and Larger Choroid Plexus Explain Cognition and Fatigue in Multiple Sclerosis

Paolo Preziosa,Elisabetta Pagani,Alessandro Meani,Loredana Storelli,Monica Margoni,Yury Yudin,Nicolò Tedone,Diana Biondi,Martina Rubin,Maria A Rocca,Massimo Filippi

DOI: https://doi.org/10.1212/NXI.0000000000200205

Abstract:Background and objectives: Chronic inflammation may contribute to cognitive dysfunction and fatigue in patients with multiple sclerosis (MS). Paramagnetic rim lesions (PRLs) and choroid plexus (CP) enlargement have been proposed as markers of chronic inflammation in MS being associated with a more severe disease course. However, their relation with cognitive impairment and fatigue has not been fully explored yet. Here, we investigated the contribution of PRL number and volume and CP enlargement to cognitive impairment and fatigue in patients with MS. Methods: Brain 3T MRI, neurologic evaluation, and neuropsychological assessment, including the Brief Repeatable Battery of Neuropsychological Tests and Modified Fatigue Impact Scale, were obtained from 129 patients with MS and 73 age-matched and sex-matched healthy controls (HC). PRLs were identified on phase images of susceptibility-weighted imaging, whereas CP volume was quantified using a fully automatic method on brain three-dimensional T1-weighted and fluid-attenuated inversion recovery MRI sequences. Predictors of cognitive impairment and fatigue were identified using random forest. Results: Thirty-six (27.9%) patients with MS were cognitively impaired, and 31/113 (27.4%) patients had fatigue. Fifty-nine (45.7%) patients with MS had ≥1 PRLs (median = 0, interquartile range = 0;2). Compared with HC, patients with MS showed significantly higher T2-hyperintense white matter lesion (WM) volume; lower normalized brain, thalamic, hippocampal, caudate, cortical, and WM volumes; and higher normalized CP volume (p from <0.001 to 0.040). The predictors of cognitive impairment (relative importance) (out-of-bag area under the curve [OOB-AUC] = 0.707) were normalized brain volume (100%), normalized caudate volume (89.1%), normalized CP volume (80.3%), normalized cortical volume (70.3%), number (67.3%) and volume (66.7%) of PRLs, and T2-hyperintense WM lesion volume (64.0%). Normalized CP volume was the only predictor of the presence of fatigue (OOB-AUC = 0.563). Discussion: Chronic inflammation, with higher number and volume of PRLs and enlarged CP, may contribute to cognitive impairment in MS in addition to gray matter atrophy. The contribution of enlarged CP in explaining fatigue supports the relevance of immune-related processes in determining this manifestation independently of disease severity. PRLs and CP enlargement may contribute to the pathophysiology of cognitive impairment and fatigue in MS, and they may represent clinically relevant therapeutic targets to limit the impact of these clinical manifestations in MS.
The T1-dark-rim: A novel imaging sign for detecting smoldering inflammation in multiple sclerosis

Pablo Naval-Baudin,Albert Pons-Escoda,Albert Castillo-Pinar,Ignacio Martínez-Zalacaín,Pablo Arroyo-Pereiro,Susanie Flores-Casaperalta,Francis Garay-Buitron,Nahum Calvo,Antonio Martinez-Yélamos,Mónica Cos,Sergio Martínez-Yélamos,Carles Majós

DOI: https://doi.org/10.1016/j.ejrad.2024.111358

IF: 4.531

2024-02-07

European Journal of Radiology

Abstract:Purpose Paramagnetic rim lesions (PRLs), usually identified in susceptibility-weighted imaging (SWI), are a promising prognostic biomarker of disability progression in multiple sclerosis (MS). However, SWI is not routinely performed in clinical practice. The objective of this study is to define a novel imaging sign, the T1-dark rim, identifiable in a standard 3DT1 gradient-echo inversion-recovery sequence, such as 3D T1 turbo field echo (3DT1FE) and explore its performance as a SWI surrogate to define PRLs. Methods This observational cross-sectional study analyzed MS patients who underwent 3T magnetic resonance imaging (MRI) including 3DT1TFE and SWI. Rim lesions were evaluated in 3DT1TFE, processed SWI, and SWI phase and categorized as true positive, false positive, or false negative based on the value of the T1-dark rim in predicting SWI phase PRLs. Sensitivity and positive predictive values of the T1-dark rim for detecting PRLs were calculated. Results Overall, 80 rim lesions were identified in 63 patients (60 in the SWI phase and 78 in 3DT1TFE; 58 true positives, 20 false positives, and two false negatives). The T1-dark rim demonstrated 97% sensitivity and 74% positive predictive value for detecting PRLs. More PRLs were detected in the SWI phase than in processed SWI (60 and 57, respectively). Conclusion The T1-dark rim sign is a promising and accessible novel imaging marker to detect PRLs whose high sensitivity may enable earlier detection of chronic active lesions to guide MS treatment escalation. The relevance of T1-dark rim lesions that are negative on SWI opens up a new field for analysis.

radiology, nuclear medicine & medical imaging

Effects of temperature on the experimental reliability of the isolated rat phrenic nerve/diaphragm preparation.

Determinants of long‐term paramagnetic rim lesion evolution in people with multiple sclerosis

Paramagnetic rim lesions are associated with inner retinal layer thinning and progression independent of relapse activity in multiple sclerosis

Longitudinal Multiparametric Quantitative MRI Evaluation of Acute and Chronic Multiple Sclerosis Paramagnetic Rim Lesions

Prognostic significance of paramagnetic rim lesions in multiple sclerosis: A systematic review

Evaluation of the Blood‐Brain Barrier, Demyelination, and Neurodegeneration in Paramagnetic Rim Lesions in Multiple Sclerosis on 7 Tesla MRI

Paramagnetic Rim Lesions are Highly Specific for Multiple Sclerosis in Real-World Data

The effect of a single dose of cyclophosphamide on the kinetics of antibody production in the guinea pig.

Chronic active lesions preferentially localize in watershed territories in multiple sclerosis

Multicenter validation of automated detection of paramagnetic rim lesions on brain MRI in multiple sclerosis

Paramagnetic rim lesions as a biomarker to discriminate between multiple sclerosis and cerebral small vessel disease

Clinical relevance of paramagnetic rim lesion heterogeneity in multiple sclerosis

The contribution of paramagnetic rim and cortical lesions to physical and cognitive disability at multiple sclerosis clinical onset: evaluating the power of MRI and OCT biomarkers

Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosis

History of diagnostic enzymology: a review of significant investigations.

Impact of paramagnetic rim lesions on disability and race in multiple sclerosis: mediation analysis

Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis

Using the Progression Independent of Relapse Activity Framework to Unveil the Pathobiological Foundations of Multiple Sclerosis

Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life setting

Chronic Active Lesions and Larger Choroid Plexus Explain Cognition and Fatigue in Multiple Sclerosis

The T1-dark-rim: A novel imaging sign for detecting smoldering inflammation in multiple sclerosis